期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

小剂量沙利度胺联合MP方案治疗初治多发性骨髓瘤32例 被引量：2

Low -dose thalidomide combined with MP in the treatment of 32 multiple myeloma cases
下载PDF
导出
摘要 目的:探讨沙利度胺联合MP方案治疗多发性骨髓瘤的疗效。方法:对应用沙利度胺联合MP治疗的32例患者的临床资料进行回顾性分析。结果:初治病例32例给予沙利度胺联合MP方案治疗,总有效率为81.2%。结论:沙利度胺联合MP方案治疗初治多发性骨髓瘤具有缓解率优于以往的常规MP方案治疗,且副作用少,耐受性好,疗效确切。 Objective：To discuss the clinical efficacy of thalidomide combined with MP in patients with multiple myeloma.Methods：Clinical data of 32 patients with newly diagnosed multiple myelom treated by thalidomide combined with MP was analyzed retrospectively.Results：All 32 patients with newly diagnosed multiple myeloma were treated by thalidomide combined with MP,the total effective rate was 81.2%.Conclusion：Thalidomide combined with MP in the treatment of newly diagnosed multiple myelom is better than that of conventional therapy scheme（MP）,and with less side effects,good tolerance.
作者 王志芳 刘非 李金红 孟祥玲 赵恩锋
机构地区 河北省沧州中西医结合医院血液内科
出处 《现代肿瘤医学》 CAS 2013年第8期1850-1851,共2页 Journal of Modern Oncology
关键词 沙利度胺 多发性骨髓瘤 MP方案 thalidomide multiple myeloma melphalan plus prednisone
分类号 R733.3 [医药卫生—肿瘤]
  • 相关文献

参考文献9

二级参考文献64

  • 1季艳霞,姜达,康振桥.沙立度胺对人乳腺癌细胞增殖及血管内皮生长因子表达的影响[J].肿瘤学杂志,2005,11(1):26-28. 被引量：7
  • 2张中林,刘志苏,孙权.反应停对人肝细胞癌生长侵袭的作用[J].中华实验外科杂志,2005,22(8):933-935. 被引量：8
  • 3Thompson MA,Witzig TE,Kumar S,et al.Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma[J].Br J Haematol,2003,123(2):305-308.
  • 4Zhang N,Ahsan MH,Zhu L,et al.NF-κB and not the MAPK signaling pathway regulates GADD45 β expression during acute inflammation[J].J Biolo Chem,2005,280(22):21400-21408.
  • 5Michael EF.Thalidomide[J].The Lancet,2004,363:1802.
  • 6Dredge K,Dalgleish AG,Marriott JB.Thalidomide analogs as emerging anti-cancer clings[J].Anticancer Drugs,2003,14(5):331-335.
  • 7Verheul HM,Panigrahy D,Yuan J,et al.Combination oral antiangiogenic therapy with thalidomide and sulindac inhibis tumour growth in rabbits[J].Br J Cancer,1999,79(1):114-118.
  • 8Yabu T,Tomimoto H,Taguchi Y,et al.Thalidomide-induced anti-angiogenic action is mediated by ceramide through depletion of VEGF receptors,and antagonized by sphingusine-1-phosphate[J].Blood,2005,10:1182.
  • 9Fujita J.Thalidomide and its analogues inhibite lipopoly saccharide-mediated induction of cyclooxygensase-2[J].Clin Cancer Res,2001,7:3349.
  • 10Settles B,Stevenson A,Wilson K,et al.Down regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vivo treatment with the anti-TNF-alpha agent thalidomide[J].Cell Mol Biol(Noisy-le-grand),2001,47(7):1105-1114.

共引文献673

同被引文献15

  • 1何立丽,张伟京,苏航,徐东刚.Ang-2与VEGF的协同作用及其在抗肿瘤血管新生治疗中的应用[J].中国实验血液学杂志,2007,15(2):445-448. 被引量：12
  • 2Bhaskar A, Gupta R, Sreenivas V, et al. Synergistic effect of vascu- lar endothelial growth factor and angiopoietin -2 on progression free survival in multiple myeloma [ J ]. Leuk Res,2013,37 ( 4 ) :410 -415.
  • 3Patan S. Vasculogenesis and angiogenesis [ J ]. Cancer Treat Res, 2004,117:3 -32.
  • 4Tomic TF, Gustavsson H, Wang W, et al. Castration resistant pros- tate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang - 2 [ J ]. Prostate, 2012,72 (7) :705 -712.
  • 5Engin H, Ustundag Y ,Tekin IO, et al. Plasma concentrations of an- giopoietin - 1, angiopoietin - 2 and Tie - 2 in colon cancer[ J ]. Eur Cytokine Netw,2012,23 (2) :68 - 71.
  • 6Hou HA, Chou WC, Lin LI, et al. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia [ J ]. Leuk Res,2008,32 ( 6 ) : 904 - 912.
  • 7Andersen NF, Vogel U, Klausen TW, et al. Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the effi- cacy of thalidomide in multiple myeloma [ J ]. Int J Cancer, 2012, 131 (5) :E636 -642.
  • 8Seki R, Yamagishi S, Matsui T, et al. Pigment epithelium - derived factor (PEDF) inhibits survival and proliferation of VEGF -ex- posed multiple myeloma cells through its anti - oxidative proper- ties[ J ]. Biochem Biophys Res Commun, 2013,431 ( 4 ) : 693 - 697.
  • 9Daly C, Eiehten A, Castanaro C, et al. Angiopoietin - 2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition[J]. Cancer Res,2013,73( 1 ) :108 -118.
  • 10Andersen NF, Vogel U, Klausen TW, et al. Vascular endothelial growth factor(VEGF) gene polymorphisms may influence the efficacy of tha- lidomide in multiple myeloma [ J 1. Int J Cancer, 2012, 131 ( 5 ) : E636 -E642.

引证文献2

二级引证文献2

现代肿瘤医学
2013年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部